SANG TRADING AND PHARMACEUTICAL COMPANY LIMITED (CÔNG TY TNHH THƯƠNG MẠI VÀ DƯỢC PHẨM SANG), operating under Tax Code 0310631333, has steadily evolved into a rising player in Vietnam’s competitive pharmaceutical distribution and medical equipment market. Headquartered at 11/9 Ngo Quang Huy, Thao Dien Ward, Thu Duc City, Ho Chi Minh City, the company combines commercial agility with a broad national footprint, including warehousing in Cat Lai and Tan Tao Industrial Parks and a branch office in Da Nang.

Founded in 2011, SANG PHARMA is a privately held enterprise with a lean workforce of 150 employees, guided by Director Le Quynh Lien. The company engages in trading pharmaceuticals, medical devices, and household chemical products while also operating in wholesale and retail sales channels. Its portfolio of registered activities spans across personal care manufacturing, transportation, logistics, and construction materials distribution—reflecting an unusually diverse operating license structure for a pharmaceutical firm.

Financially, the company ended 2023 on a significantly improved note. Revenue stood at USD 172.35 million, with net profit climbing to USD 842,534—a 137% year-over-year increase, signaling renewed profitability after a period of volatility. Though revenue has slightly contracted over the last two years, total assets surged to USD 62 million, and owner’s equity rose to nearly USD 1.8 million, showing a 49.6% annual increase. The company maintains positive working capital of USD 1.67 million, a sign of operational solvency and improved liquidity.

Backed by a group of Vietnamese shareholders, including Banh Gia Hao (27%) and Bui Thi Giang (22%), SANG PHARMA demonstrates a locally rooted yet professionally structured ownership model. Nevertheless, the wide-ranging business licenses and fluctuating historical earnings call for measured evaluation—especially for prospective partners, insurers, and procurement managers seeking transparency.

Before engaging in high-value transactions or long-term contracts, it is advisable to request a full Vietnam Company Report, along with Litigation Checks, Private Financial Data Analysis, and Risk Management Services from VANGUARD BUSINESS INFORMATION LLC (VBI). These services provide verified insights beyond surface-level data and help clients ensure credibility, financial health, and compliance.

In a pharmaceutical market defined by rapid growth, global sourcing pressures, and regulatory scrutiny, SANG PHARMA is a company to watch—not just for its product distribution capacity but for how it navigates complexity in a highly regulated sector.